| 000 | 01675 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516211528.0 | ||
| 264 | 0 | _c20150314 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1469-4409 | ||
| 024 | 7 |
_a10.1017/S0950268814000855 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFreeman, G | |
| 245 | 0 | 0 |
_aMultivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children. _h[electronic resource] |
| 260 |
_bEpidemiology and infection _cFeb 2015 |
||
| 300 |
_a540-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHemagglutination Inhibition Tests |
| 650 | 0 | 4 | _aHong Kong |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza A Virus, H3N2 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza B virus _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aVaccines, Inactivated _xadministration & dosage |
| 700 | 1 | _aNg, S | |
| 700 | 1 | _aPerera, R A P M | |
| 700 | 1 | _aFang, V J | |
| 700 | 1 | _aIp, D K M | |
| 700 | 1 | _aLeung, G M | |
| 700 | 1 | _aPeiris, J S M | |
| 700 | 1 | _aCowling, B J | |
| 773 | 0 |
_tEpidemiology and infection _gvol. 143 _gno. 3 _gp. 540-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0950268814000855 _zAvailable from publisher's website |
| 999 |
_c23786907 _d23786907 |
||